|
EIF2B3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.215300E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.89120000000066E-05 |
| Normal-vs-Stage2 |
1.543870E-03 |
| Normal-vs-Stage3 |
3.724400E-02 |
| Normal-vs-Stage4 |
6.359500E-02 |
| Stage1-vs-Stage2 |
5.351800E-01 |
| Stage1-vs-Stage3 |
1.344380E-01 |
| Stage1-vs-Stage4 |
3.998200E-01 |
| Stage2-vs-Stage3 |
8.786000E-02 |
| Stage2-vs-Stage4 |
2.307600E-01 |
| Stage3-vs-Stage4 |
7.918400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.564200E-04 |
| Normal-vs-AfricanAmerican |
5.723100E-03 |
| Normal-vs-Asian |
2.294400E-02 |
| Caucasian-vs-AfricanAmerican |
7.338400E-02 |
| Caucasian-vs-Asian |
9.073800E-01 |
| AfricanAmerican-vs-Asian |
1.677800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.776400E-01 |
| Normal-vs-Female |
4.24560000000795E-06 |
| Male-vs-Female |
2.141200E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.29690000000238E-05 |
| Normal-vs-Age(41-60Yrs) |
6.200000E-03 |
| Normal-vs-Age(61-80Yrs) |
2.782600E-03 |
| Normal-vs-Age(81-100Yrs) |
7.187400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.084160E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.158600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.124000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.568800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.834800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.210200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.275600E-01 |
| Classical-VS-Follicular |
4.648200E-02 |
| Classical-VS-Other |
6.190400E-01 |
| Classical-VS-Normal |
9.632700E-04 |
| Tall-VS-Follicular |
8.758400E-02 |
| Tall-VS-Other |
6.762200E-01 |
| Tall-VS-Normal |
4.377600E-02 |
| Follicular-VS-Other |
2.406000E-01 |
| Follicular-VS-Normal |
8.49300000000941E-05 |
| Other-VS-Normal |
8.691400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.3724999999959E-05 |
| Normal-vs-N1 |
9.353600E-01 |
| N0-vs-N1 |
4.758000E-03 |
|
|
